Beneficient Reports Net Income of $5.94 Million for Q4 2025, Despite Nine-Month Loss of $104.62 Million

Beneficient, a technology-enabled financial services company, reported its financial results for the quarter ended December 31, 2025, revealing a net income of $5.94 million, a significant turnaround from the net loss of $10.23 million reported for the same period in 2024. However, for the nine months ended December 31, 2025, the company reported a net loss of $104.62 million, compared to a net income of $43.83 million for the same period in 2024. The company's revenues for the quarter stood at $18.67 million, compared to $4.42 million for the same period in 2024, while for the nine months ended December 31, 2025, revenues were $3.28 million, compared to $23.03 million for the same period in 2024. The company's financial performance is significantly influenced by the fair value of investments held by Customer ExAlt Trusts, which are consolidated for financial reporting purposes.

A key factor impacting Beneficient's financial results is the consolidation of Customer ExAlt Trusts, which are variable interest entities (VIEs) but not directly owned by the company's equity holders. Transactions between Beneficient's operating subsidiaries and these trusts are eliminated in the consolidated financial statements. This means that while the consolidated statements reflect the assets, liabilities, revenues, and expenses of both Beneficient and the Customer ExAlt Trusts, the interest and fee income earned by Beneficient's operating subsidiaries from these trusts, which are eliminated in consolidation, directly impact the net income attributable to Beneficient's equity holders. The company's primary tangible assets are investments, mainly alternative assets held by the Customer ExAlt Trusts, and the primary revenue sources are investment income (loss), net, and gain (loss) on financial instruments, net, which represent changes in the net asset value (NAV) of these investments.

During the quarter, Beneficient experienced significant fluctuations in its financial instruments. The gain on financial instruments, net, increased by $43.85 million, primarily due to a $44.06 million increase in the fair value of a derivative asset. This was partially offset by a $0.12 million decrease in the fair value of the warrants liability and a $0.10 million decrease in the fair value of public equity securities. The company's operating expenses for the quarter totaled $14.73 million, compared to $13.93 million for the same period in 2024. For the nine months ended December 31, 2025, operating expenses totaled $109.85 million, compared to $1.92 million for the same period in 2024. The increase was primarily due to a $62.83 million accrual of a loss contingency related to an arbitration award.

Beneficient faces substantial doubt about its ability to continue as a going concern, as indicated by its accumulated deficit of $2.06 billion as of December 31, 2025, and its contractual obligations exceeding $126 million. The company's ability to meet its obligations and fund operations depends on additional capital, which it intends to secure through debt or equity issuances, including a Standby Equity Purchase Agreement (SEPA) with Yorkville, and the monetization of investments held by the Customer ExAlt Trusts. The company is also evaluating options regarding an equity arbitration award, which may include appealing to the Texas Supreme Court or negotiating settlement terms. To maintain its listing on the Nasdaq, Beneficient implemented a reverse stock split in December 2025. The company is also working with lenders on waivers related to defaults on certain payment obligations, financial covenants, and information reporting requirements.